A report from the Innovation Economy Council, an industry coalition, argues that Canada’s biomanufacturing strategy must look beyond vaccines and move into the even more important field cell and gene therapies. Federal support will be crucial to ensuring that these facilities are located in innovation centres across the country where they can thrive.
Organization: Innovation Economy Council
The Short Report – May 20, 2020: Last network renewals for sunsetting NCE program; New accelerator targets healthy living; Canadian health research at “elevated risk” for hacking; and more
The Networks of Centres of Excellence has awarded $80.7 million in funding to five networks – the last cohorts to be renewed as the NCE program begins winding down over the next few years. Three-year renewals were granted to: Aging Gracefully across Environments using Technology to support Wellness, Engagement and Long Life (AGE-WELL) ($22 million);…
The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more
Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...